Skip to main content
VCbacked
Log inGet Started

Daybreak Health

San Francisco, United States

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

$13.0M raised
Aug 2023
Series B
Health CareMental HealthMobile AppsPersonal HealthTherapeutics

Top Investors

Y CombinatorLightspeed Venture PartnersUnion Square VenturesLux CapitalSignalRank

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Daybreak Health

How much funding has Daybreak Health raised?
Daybreak Health has raised $13.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Who are Daybreak Health's investors?
Daybreak Health's investors include Y Combinator, Lightspeed Venture Partners, Union Square Ventures, Lux Capital, SignalRank.
Where is Daybreak Health headquartered?
Daybreak Health is headquartered in San Francisco, United States.
What does Daybreak Health do?
Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.
What stage is Daybreak Health at?
Daybreak Health is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Daybreak Health — Funding & Investors." VCBacked, August 8, 2023, https://www.vcbacked.co/company/daybreak-health. Accessed June 4, 2026.
APA
VCBacked. (2023). Daybreak Health — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/daybreak-health
Wikipedia (cite web)
{{cite web |title=Daybreak Health — Funding & Investors |url=https://www.vcbacked.co/company/daybreak-health |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K